Blood News and Research

RSS

Genetic variation alters response to anti-clotting drug warfarin

Millions of people take the anticoagulant drug warfarin to prevent harmful clotting after a heart attack, stroke, or major surgery. But the proper dose of warfarin can vary greatly and can be hard to predict.

1 Jun 2005

Early surgical removal of the spleen combined with antiangiogenic cancer therapy may halt the progression of leukemia

The research, published today in Blood, is the first to show the combination of two factors secreted from the environment of the spleen is important in the promotion of leukemia.

1 Jun 2005

You can teach your child to eat healthier

Parents, take heart: You can teach your child to eat healthier. A study of preadolescent children found that those who attended a behaviorally oriented nutrition education program and were taught to follow a diet low in saturated fat and dietary cholesterol adopted significantly better dietary habits over several years compared to their peers who received only general nutritional information.

1 Jun 2005

Study of MRSA bloodstream infections in children

The UK's Health Protection Agency (HPA) is to begin a study reviewing bloodstream infections in children caused by methicillin-resistant Staphylococcus aureus (MRSA).

1 Jun 2005

Hypertension, diabetes and obesity are important independent predictors of increased complications for patients undergoing major joint replacement surgery

Using a database of nearly 1 million Americans who underwent major joint replacement surgery, a team led by researchers at Duke University Medical Center have determined those surgical patients with diabetes, hypertension or obesity were significantly more likely to suffer post-operative complications.

1 Jun 2005

New Calcitonin drug delivery research holds promise for osteoporosis sufferers

Calcitonin, a hormone that lowers calcium levels in the blood and prevents bone loss, has only been available in an injectable and nasally-administered format to date.

1 Jun 2005

Triple approach is promising against cancer cells

A trimodal treatment strategy combining chemotherapy, radiation therapy, and a protein kinase inhibitor is much more effective against cancer cells than any combination of only two treatment methods.

1 Jun 2005

Heart doctors say off-pump or on-pump, no difference in bypass surgery

As far as the American Heart Association (AHA) is concerned, the long running debate over whether patients undergoing coronary bypass surgery do better if their hearts keep beating or if a heart-lung machine takes over should end.

1 Jun 2005

Diabetics more sensitive to cardiovascular effects from air pollution

People with diabetes may be at higher risk for cardiovascular problems when air pollution levels are higher, according to a new study of Boston-area residents. The ability of the blood vessels to control blood flow was impaired in adults with diabetes on days with elevated levels of particles from traffic and coal-burning power plants.

31 May 2005

We have been ingrained to think that seriously large people can only make improvements in their health if they diet and slim down

Behavior change and self-acceptance trump dieting hands-down when it comes to achieving long-term health improvements in obese women, according to a two-year study by nutrition researchers at the University of California, Davis.

31 May 2005

Long-haul flights, length of time under anesthesia increase risk of developing blood clots

The prolonged immobility of flight passengers during long-haul air travel increases the risk of developing blood clots, which could prove fatal especially to people whose travel occurs just prior to major surgery, medical researchers report in the current issue of Mayo Clinic Proceedings.

31 May 2005

New approach to inhibiting blood vessel growth or angiogenesis

A manmade protein with a tail of amino acids delivered to target cells can dramatically reduce blood vessel growth that obstructs vision or feeds a tumor, researchers have found.

31 May 2005

Targepeutics issued new U.S patent

Targepeutics has announced the issuance of U.S. Patent No. 6,884,603 for its genetically modified, mutated Interleukin 13 (IL-13) technology platform for the treatment of malignant glioma, a brain tumor (17,500 people annually; $200 million annual market).

31 May 2005

Shock wave therapy shows remarkable results in wound healing and curing myocardial diseases

Effective, non-invasive and practically without side effects - extracorporeal shock wave therapy has demonstrated impressive results not only in orthopedics and traumatology, but also in treating fresh and chronic wounds as well as circulatory disorders of the myocardial muscle.

31 May 2005